← 治験一覧に戻る
頭頸部がんに対する線量最適化BNCT
基本情報
- NCT ID
- NCT05883007
- ステータス
- 不明
- 試験のフェーズ
- 第1相
- 試験タイプ
- 介入
- 目標被験者数
- 30
- 治験依頼者名
- Southern Tohoku BNCT Research Center
概要
The goal of this clinical trial is to evaluate the safety of applying BNCT with the dose optimization in patients with recurrent head and neck cancer. The main questions it aims to answer are: \- Dose optimized BNCT are conducted safety in these patients. Participants will receive dose optimized BNCT regulated as 12, 15, 18 Gy-Eq of the mucosal dose.
対象疾患
Head and Neck CancerSquamous Cell Carcinoma
介入
Accelerator-based BNCT with borofalan(10B)(RADIATION)
依頼者(Sponsor)
実施施設 (1)
総合南東北病院
Kōriyama, Fukushima, Japan